Sarcome-13/OS2016 trial protocol: a multicentre, randomised, open-label, phase II trial of mifamurtide combined with postoperative chemotherapy for patients with newly diagnosed high-risk osteosarcoma

INTRODUCTION: The controversial results on the mifamurtide efficacy associated with chemotherapy, issued from the American INT-0133-study, in localised osteosarcomas, and the underpowered analysis performed separately in metastatic patients, should be clarified to homogenise international use of thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Brard, Caroline, Piperno-Neumann, Sophie, Delaye, Jessy, Brugières, Laurence, Hampson, Lisa V, Le Teuff, Gwénaël, Le Deley, Marie-Cécile, Gaspar, Nathalie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530327/
https://www.ncbi.nlm.nih.gov/pubmed/31110092
http://dx.doi.org/10.1136/bmjopen-2018-025877

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530327/
https://www.ncbi.nlm.nih.gov/pubmed/31110092
http://dx.doi.org/10.1136/bmjopen-2018-025877

Ejemplares similares